AIM: To investigate the expressions of micro RNA-20a(mi R-20a) and let-7a in esophageal squamous cell carcinoma(ESCC) and their diagnostic value. METHODS: Seventy patients with ESCC and 40 healthy subjects were enroll...AIM: To investigate the expressions of micro RNA-20a(mi R-20a) and let-7a in esophageal squamous cell carcinoma(ESCC) and their diagnostic value. METHODS: Seventy patients with ESCC and 40 healthy subjects were enrolled to investigate the expression of mi R-20 a and let-7a using quantitative real-time PCR. The expression of mi R-20 a and let-7a was compared between ESCC patients and healthy subjects. The plasma levels of mi R-20 a and let-7a in relation to patient clinicopathologic parameters, the receiver operating characteristic(ROC) curve, and the sensitivity and specificity of mi R-20 a and let-7a in ESCC diagnosis were analyzed.RESULTS: Plasma levels of mi R-20 a were significantly higher in ESCC patients than in healthy controls, and plasma levels of let-7 were lower in ESCC patients than in healthy controls(both P < 0.05). The area under the ROC curve of mi R-20 a was 0.767(95%CI: 0.677-0.857; P < 0.001), when the cut-off value was set at 4.77, the sensitivity and specificity were 64.3% and 75.0%, respectively. The area under the ROC curve of let-7a was 0.829(95%CI: 0.754-0.904; P < 0.001), when the cut-off value was set at 6.22, the sensitivity and specificity were 74.3% and 85.0%, respectively. Thus, the sensitivity and specificity of let-7a were higher than those of mi R-20 a. The median relative plasma expression of let-7a in clinical stage Ⅲ/Ⅳ(0.24) was lower than that in stage Ⅰ/Ⅱ(0.42), while the expression of mi R-20 a according to stage was not statistically different. The expressions of mi R-20 a and let-7a were not related to gender, age, tumor diameter, tumor grade, or pathologic stage.CONCLUSION: Plasma mi R-20 a and let-7a levels are significantly altered in patients with ESCC and can be used as potential biomarkers in the diagnosis of ESCC.展开更多
【目的】探究环指蛋白20(ring finger protein 20,RNF20)对小鼠性腺脂肪组织(gonadal white adipose tissues,gWAT)及3T3-L1脂肪细胞中支链氨基酸(branched-chain amino acids,BCAAs)代谢的影响及调控机制。【方法】以雄性脂肪特异性Rn...【目的】探究环指蛋白20(ring finger protein 20,RNF20)对小鼠性腺脂肪组织(gonadal white adipose tissues,gWAT)及3T3-L1脂肪细胞中支链氨基酸(branched-chain amino acids,BCAAs)代谢的影响及调控机制。【方法】以雄性脂肪特异性Rnf20基因敲除小鼠(Rnf20^(flox/flox);adiponectin-Cre^(+),ASKO)及同窝野生型小鼠(Rnf20^(flox/flox);adiponectin-Cre^(-),WT)为研究对象,通过靶向代谢组学检测小鼠gWAT和血清中BCAAs含量,结合实时荧光定量PCR分析gWAT、肝脏及腓肠肌中BCAAs分解代谢基因(Bcat2、Bckdha等)的表达情况。利用siRNA干扰3T3-L1前体脂肪细胞内源性Rnf20基因表达,并诱导细胞成脂分化,通过油红O染色评估siRNF20(干扰组)和siNC(对照组)细胞的成脂分化效率,检测成脂分化标志基因、脂肪水解基因及BCAAs分解代谢基因的表达情况以及脂肪细胞培养基中BCAAs的含量。【结果】与WT小鼠相比,ASKO小鼠gWAT中BCAAs(亮氨酸、异亮氨酸、缬氨酸)含量均极显著升高(P<0.01),且BCAAs分解代谢相关基因Bcat2、Acad5、Ehhand、Hibch表达量显著或极显著降低(P<0.05;P<0.01);而血清中BCAAs含量及肝脏、腓肠肌中BCAAs分解代谢相关基因表达量均无显著变化(P>0.05)。与siNC组相比,体外敲除Rnf20基因可抑制3T3-L1细胞成脂分化,其中成脂标志基因Pparγ表达量显著降低(P<0.05),脂肪水解基因Adrb3表达量极显著升高(P<0.01);成熟脂肪细胞中BCAAs分解代谢关键基因Bcat2、Bckdha表达量随Rnf20基因敲除而降低,且siRNF20组培养基中BCAAs含量极显著升高(P<0.01)。【结论】脂肪细胞Rnf20基因通过转录调控BCAAs分解代谢关键基因(Bcat2、Bckdha),维持细胞内BCAAs稳态;敲除Rnf20基因可抑制BCAAs分解代谢,导致BCAAs在脂肪组织内累积。研究结果为深入探究Rnf20基因功能提供了新的方向,为大动物脂肪沉积性状研究提供了新的基因素材。展开更多
基金Supported by Medical Scientific Research Foundation of Health Department of Henan Province of China,No.201403077
文摘AIM: To investigate the expressions of micro RNA-20a(mi R-20a) and let-7a in esophageal squamous cell carcinoma(ESCC) and their diagnostic value. METHODS: Seventy patients with ESCC and 40 healthy subjects were enrolled to investigate the expression of mi R-20 a and let-7a using quantitative real-time PCR. The expression of mi R-20 a and let-7a was compared between ESCC patients and healthy subjects. The plasma levels of mi R-20 a and let-7a in relation to patient clinicopathologic parameters, the receiver operating characteristic(ROC) curve, and the sensitivity and specificity of mi R-20 a and let-7a in ESCC diagnosis were analyzed.RESULTS: Plasma levels of mi R-20 a were significantly higher in ESCC patients than in healthy controls, and plasma levels of let-7 were lower in ESCC patients than in healthy controls(both P < 0.05). The area under the ROC curve of mi R-20 a was 0.767(95%CI: 0.677-0.857; P < 0.001), when the cut-off value was set at 4.77, the sensitivity and specificity were 64.3% and 75.0%, respectively. The area under the ROC curve of let-7a was 0.829(95%CI: 0.754-0.904; P < 0.001), when the cut-off value was set at 6.22, the sensitivity and specificity were 74.3% and 85.0%, respectively. Thus, the sensitivity and specificity of let-7a were higher than those of mi R-20 a. The median relative plasma expression of let-7a in clinical stage Ⅲ/Ⅳ(0.24) was lower than that in stage Ⅰ/Ⅱ(0.42), while the expression of mi R-20 a according to stage was not statistically different. The expressions of mi R-20 a and let-7a were not related to gender, age, tumor diameter, tumor grade, or pathologic stage.CONCLUSION: Plasma mi R-20 a and let-7a levels are significantly altered in patients with ESCC and can be used as potential biomarkers in the diagnosis of ESCC.
文摘【目的】探究环指蛋白20(ring finger protein 20,RNF20)对小鼠性腺脂肪组织(gonadal white adipose tissues,gWAT)及3T3-L1脂肪细胞中支链氨基酸(branched-chain amino acids,BCAAs)代谢的影响及调控机制。【方法】以雄性脂肪特异性Rnf20基因敲除小鼠(Rnf20^(flox/flox);adiponectin-Cre^(+),ASKO)及同窝野生型小鼠(Rnf20^(flox/flox);adiponectin-Cre^(-),WT)为研究对象,通过靶向代谢组学检测小鼠gWAT和血清中BCAAs含量,结合实时荧光定量PCR分析gWAT、肝脏及腓肠肌中BCAAs分解代谢基因(Bcat2、Bckdha等)的表达情况。利用siRNA干扰3T3-L1前体脂肪细胞内源性Rnf20基因表达,并诱导细胞成脂分化,通过油红O染色评估siRNF20(干扰组)和siNC(对照组)细胞的成脂分化效率,检测成脂分化标志基因、脂肪水解基因及BCAAs分解代谢基因的表达情况以及脂肪细胞培养基中BCAAs的含量。【结果】与WT小鼠相比,ASKO小鼠gWAT中BCAAs(亮氨酸、异亮氨酸、缬氨酸)含量均极显著升高(P<0.01),且BCAAs分解代谢相关基因Bcat2、Acad5、Ehhand、Hibch表达量显著或极显著降低(P<0.05;P<0.01);而血清中BCAAs含量及肝脏、腓肠肌中BCAAs分解代谢相关基因表达量均无显著变化(P>0.05)。与siNC组相比,体外敲除Rnf20基因可抑制3T3-L1细胞成脂分化,其中成脂标志基因Pparγ表达量显著降低(P<0.05),脂肪水解基因Adrb3表达量极显著升高(P<0.01);成熟脂肪细胞中BCAAs分解代谢关键基因Bcat2、Bckdha表达量随Rnf20基因敲除而降低,且siRNF20组培养基中BCAAs含量极显著升高(P<0.01)。【结论】脂肪细胞Rnf20基因通过转录调控BCAAs分解代谢关键基因(Bcat2、Bckdha),维持细胞内BCAAs稳态;敲除Rnf20基因可抑制BCAAs分解代谢,导致BCAAs在脂肪组织内累积。研究结果为深入探究Rnf20基因功能提供了新的方向,为大动物脂肪沉积性状研究提供了新的基因素材。
